Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 1505-1508, March 15, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Castelli, M. G.
Right arrow Articles by Paoletti, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Castelli, M. G.
Right arrow Articles by Paoletti, P.

Prostaglandin and Thromboxane Synthesis by Human Intracranial Tumors1

Maria Grazia Castelli, Chiara Chiabrando2, Roberto Fanelli, Luciana Martelli, Giorgio Butti, Paolo Gaetani and Pietro Paoletti

Istituto di Ricerche Farmacologiche "Mario Negri", Via Eritrea 62, 20157, Milan, Italy [M. G. C., C. C., R. F., L. M.]; and the Dipartimento di Chirurgia, Sezione di Clinical Neurochirurgica, Centro "Enrica Grossi-Paoletti" per lo Studio e il Trattamento delle Neoplasie del Sistema Nervoso, Universita' di Pavia, 27100 Pavia, Italy [G. B., P. G., P. P.]

Prostaglandin (PG) and thromboxane (TX) production by homogenates of human intracranial tumors (33 gliomas, 32 meningiomas, six brain metastases) and "normal" brain (n = 26) from tumor-bearing patients was studied. PGF2{alpha}, PGE2, PGD2, 6-keto-PGF1{alpha} (the hydrolysis product of PGI2) and TXB2 (the hydrolysis product of TXA2) were determined by high-resolution gas chromatography-mass spectrometry after ex vivo metabolism of endogenous arachidonic acid. Prostanoid profiles (relative abundance of each metabolite) were different for gliomas and meningiomas, but similar for gliomas and their nontumoral counterpart, i.e., "normal" brain. Mean overall prostanoid production was significantly higher in gliomas (539 ± 95) and meningiomas (523 ± 69) than in "normal" brain (198 ± 23). Prostanoid synthesis significantly increased with anaplastic grade (glioblastomas > anaplastic astrocytomas > slow-growing astrocytomas > ‘normal" brain), while profiles did not substantially change (TXB2 was the most and 6-keto-PGF1{alpha} the least abundant product). Meningioma profiles showed no marked prevalence of any particular metabolite and no major differences between histological subgroups. All brain metastases from different carcinomas (n = 5) showed a prevalence of TXB2 and PGE2 and very low PGD2 synthesis.

1 This work was supported in part by a grant from the Italian Ministry of Education (Rome, Italy, 1986) and from the National Research Council (87.01204.44).

2 To whom requests for reprints should be addressed.

Received 7/28/88. Revised 11/23/88. Accepted 11/30/88.




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
T. Payner, H. A. Leaver, B. Knapp, I. R. Whittle, O. C. Trifan, S. Miller, and M. T. Rizzo
Microsomal prostaglandin E synthase-1 regulates human glioma cell growth via prostaglandin E2-dependent activation of type II protein kinase A.
Mol. Cancer Ther., July 1, 2006; 5(7): 1817 - 1826.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
H. H. Steiner, M. M. Bonsanto, P. Beckhove, M. Brysch, K. Geletneky, R. Ahmadi, R. Schuele-Freyer, P. Kremer, G. Ranaie, D. Matejic, et al.
Antitumor Vaccination of Patients With Glioblastoma Multiforme: A Pilot Study to Assess Feasibility, Safety, and Clinical Benefit
J. Clin. Oncol., November 1, 2004; 22(21): 4272 - 4281.
[Abstract] [Full Text] [PDF]


Home page
Integr Cancer TherHome page
J. M. Wallace
Integrative Tumor Board: Glioblastoma Multiforme: Nutritional and Botanical Approach
Integr Cancer Ther, June 1, 2004; 3(2): 152 - 163.
[PDF]


Home page
J. Clin. Pathol.Home page
N Nathoo, G H Barnett, and M Golubic
The eicosanoid cascade: possible role in gliomas and meningiomas
J. Clin. Pathol., January 1, 2004; 57(1): 6 - 13.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Shono, P. J. Tofilon, J. M. Bruner, O. Owolabi, and F. F. Lang
Cyclooxygenase-2 Expression in Human Gliomas: Prognostic Significance and Molecular Correlations
Cancer Res., June 1, 2001; 61(11): 4375 - 4381.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
G. E. Plautz, D. W. Miller, G. H. Barnett, G. H. J. Stevens, S. Maffett, J. Kim, P. A. Cohen, and S. Shu
T Cell Adoptive Immunotherapy of Newly Diagnosed Gliomas
Clin. Cancer Res., June 1, 2000; 6(6): 2209 - 2218.
[Abstract] [Full Text]


Home page
Neuro OncolHome page
A. Giese, C. Hagel, E. L. Kim, S. Zapf, J. Djawaheri, M. E. Berens, and M. Westphal
Thromboxane synthase regulates the migratory phenotype of human glioma cells
Neuro-oncol, January 1, 1999; 1(1): 3 - 13.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.